Literature DB >> 31951184

Vaccinations in Infants Born Preterm: An Update.

Areti Aphrodite Sioriki1, Despoina Gkentzi2, Evangelia Papadimitriou1, Gabriel Dimitriou2, Ageliki Karatza2.   

Abstract

Infants born prematurely (before completion of 37 weeks of gestation) are at increased risk of morbidity and mortality due to vaccine preventable diseases, mostly because of their immunological immaturity and failure of transfer of maternal protective antibodies. Despite their great need of being vaccinated, concerns on vaccine safety and efficacy, constitute the main reasons for which vaccinations are often delayed in this group. In this review we summarize the latest evidence on vaccine safety, efficacy and immunogenicity in preterm infants which is similar to full-term infants. Therefore there is no reason for delaying vaccination in this population. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Vaccinations; born; immunization; immunogenicity; morbidity; mortality; premature infants.

Mesh:

Substances:

Year:  2020        PMID: 31951184     DOI: 10.2174/1573396316666200116094459

Source DB:  PubMed          Journal:  Curr Pediatr Rev        ISSN: 1573-3963


  2 in total

Review 1.  The Fifth International Neonatal and Maternal Immunization Symposium (INMIS 2019): Securing Protection for the Next Generation.

Authors:  Manish Sadarangani; Tobias Kollmann; Gordean Bjornson; Paul Heath; Ed Clarke; Arnaud Marchant; Ofer Levy; Elke Leuridan; Rolando Ulloa-Gutierrez; Clare L Cutland; Beate Kampmann; Surasith Chaithongwongwatthana; Ener Dinleyici; Pierre van Damme; Flor M Munoz
Journal:  mSphere       Date:  2021-01-27       Impact factor: 4.389

2.  In-hospital and web-based intervention to counteract vaccine hesitancy in very preterm infants' families: a NICU experience.

Authors:  Antonio Di Mauro; Federica Di Mauro; Chiara Greco; Orazio Valerio Giannico; Francesca Maria Grosso; Maria Elisabetta Baldassarre; Manuela Capozza; Federico Schettini; Pasquale Stefanizzi; Nicola Laforgia
Journal:  Ital J Pediatr       Date:  2021-09-16       Impact factor: 2.638

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.